104 related articles for article (PubMed ID: 15686898)
21. Bacterial and mammalian HMG-CoA reductases: related enzymes with distinct architectures.
Istvan ES
Curr Opin Struct Biol; 2001 Dec; 11(6):746-51. PubMed ID: 11751057
[TBL] [Abstract][Full Text] [Related]
22. Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA).
Thilagavathi R; Kumar R; Aparna V; Sobhia ME; Gopalakrishnan B; Chakraborti AK
Bioorg Med Chem Lett; 2005 Feb; 15(4):1027-32. PubMed ID: 15686906
[TBL] [Abstract][Full Text] [Related]
23. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.
Karthik MV; Satya Deepak MV; Shukla P
Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940
[TBL] [Abstract][Full Text] [Related]
24. Discriminating of HMG-CoA reductase inhibitors and decoys using self-organizing maps.
Wang Z; Yan A
Mol Divers; 2011 Aug; 15(3):655-63. PubMed ID: 21072588
[TBL] [Abstract][Full Text] [Related]
25. Allosteric inhibitors of HMG-CoA reductase, the key enzyme involved in cholesterol biosynthesis.
Haber A; Abu-Younis Ali A; Aviram M; Gross Z
Chem Commun (Camb); 2013 Dec; 49(93):10917-9. PubMed ID: 23958894
[TBL] [Abstract][Full Text] [Related]
26. Recombinant Schistosoma mansoni 3-hydroxymethylglutaryl-coenzyme-A reductase has different inhibitor kinetics compared to the mammalian host enzyme.
El-Meanawy A; Hammd H; Chen GZ; Rottman F; Bennett JL
Trop Gastroenterol; 2005; 26(3):132-5. PubMed ID: 16512462
[TBL] [Abstract][Full Text] [Related]
27. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
28. Syntheses of some α-cyclic tripeptides as potential inhibitors for HMG-CoA Reductase.
Chakraborty S; Lin SH; Shiuan D; Tai DF
Amino Acids; 2015 Aug; 47(8):1495-505. PubMed ID: 25929584
[TBL] [Abstract][Full Text] [Related]
29. Peptide fragmentation as an approach in modeling of an active peptide and designing a competitive inhibitory peptide for HMG-CoA reductase.
Pak VV; Koo M; Kwon DY; Shakhidoyatov KM; Yun L
Bioorg Med Chem; 2010 Jun; 18(12):4300-9. PubMed ID: 20494585
[TBL] [Abstract][Full Text] [Related]
30. Binding thermodynamics of statins to HMG-CoA reductase.
Carbonell T; Freire E
Biochemistry; 2005 Sep; 44(35):11741-8. PubMed ID: 16128575
[TBL] [Abstract][Full Text] [Related]
31. DOX: A new computational protocol for accurate prediction of the protein-ligand binding structures.
Rao L; Chi B; Ren Y; Li Y; Xu X; Wan J
J Comput Chem; 2016 Jan; 37(3):336-44. PubMed ID: 26459237
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of recombinant enzyme 3-hydroxy-3-methylglutaryl-CoA reductase from Candida glabrata by α-asarone-based synthetic compounds as antifungal agents.
Andrade-Pavón D; Ortiz-Álvarez J; Sánchez-Sandoval E; Tamariz J; Hernández-Rodríguez C; Ibarra JA; Villa-Tanaca L
J Biotechnol; 2019 Feb; 292():64-67. PubMed ID: 30690093
[TBL] [Abstract][Full Text] [Related]
33. Characterization of an HMG-CoA reductase from Listeria monocytogenes that exhibits dual coenzyme specificity.
Theivagt AE; Amanti EN; Beresford NJ; Tabernero L; Friesen JA
Biochemistry; 2006 Dec; 45(48):14397-406. PubMed ID: 17128979
[TBL] [Abstract][Full Text] [Related]
34. Discovery and quantitative structure-activity relationship study of lepidopteran HMG-CoA reductase inhibitors as selective insecticides.
Zang YY; Li YM; Yin Y; Chen SS; Kai ZP
Pest Manag Sci; 2017 Sep; 73(9):1944-1952. PubMed ID: 28247468
[TBL] [Abstract][Full Text] [Related]
35. Design of a highly potent inhibitory peptide acting as a competitive inhibitor of HMG-CoA reductase.
Pak VV; Koo M; Kwon DY; Yun L
Amino Acids; 2012 Nov; 43(5):2015-25. PubMed ID: 22451276
[TBL] [Abstract][Full Text] [Related]
36. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
Pak VV; Koo M; Yun L; Kwon DY
J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
[TBL] [Abstract][Full Text] [Related]
37. The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases.
Friesen JA; Rodwell VW
Genome Biol; 2004; 5(11):248. PubMed ID: 15535874
[TBL] [Abstract][Full Text] [Related]
38. Molecular Docking, Synthesis And Biological Evaluation Of Ergosteryl-Ferulate As A Hmg-Coa Reductase Inhibitor.
Aziz S; Elfahmi -; Soemardji AA; Sukrasno -
Pak J Pharm Sci; 2020 May; 33(3):997-1003. PubMed ID: 33191223
[TBL] [Abstract][Full Text] [Related]
39. Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Sarver RW; Bills E; Bolton G; Bratton LD; Caspers NL; Dunbar JB; Harris MS; Hutchings RH; Kennedy RM; Larsen SD; Pavlovsky A; Pfefferkorn JA; Bainbridge G
J Med Chem; 2008 Jul; 51(13):3804-13. PubMed ID: 18540668
[TBL] [Abstract][Full Text] [Related]
40. [Mechanism of action of HMG-CoA reductase inhibitors. Medical-chemical aspects of statins].
Stark H
Pharm Unserer Zeit; 2003; 32(6):464-71. PubMed ID: 14639827
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
